Oryzon Genomics S.A. is the first Spanish Biomarker and Target Discovery Company with an In-Vitro Diagnostics and Therapeutic R&D pipeline focused in oncology and neurodegenerative diseases.
View Top Employees from Crystax Pharmaceuticals / Oryzon GenomicsWebsite | http://www.oryzon.com |
Ticker | BME:ORY |
Revenue | $11 million |
Funding | $54.4 million |
Employees | 52 (52 on RocketReach) |
Founded | 2000 |
Address | 74 Sant Ferran, Cornella de Llobregat, Catalonia 08940, ES |
Phone | +34 935 15 13 13 |
Fax | +34 933 77 40 28 |
Technologies |
JavaScript,
HTML,
Google Analytics
+14 more
(view full list)
|
Industry | Biotechnology, Drug Discovery, Biotechnology Research, Pharmaceuticals, Biomarker Discovery, Healthcare, Science and Engineering, Genetics, Fragment Screening, Health Care, Cancer, Medical, Neurodegeneration, Therapeutics |
Web Rank | 2 Million |
Keywords | Oryzon Genomics S.A., Ash Molecula, Barrios, E. (2016). La Gestión De La Responsabilidad Social Corporativa. Tesis Doctoral. Universidad De Barcelona. España., Definicion Epigenetica, Qué Es La Epigenética? |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 5416 Companies, NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 541 Companies, NAICS Code 54161 Companies, NAICS Code 5417 Companies, NAICS Code 541612 Companies |
Looking for a particular Crystax Pharmaceuticals / Oryzon Genomics employee's phone or email?
The Crystax Pharmaceuticals / Oryzon Genomics annual revenue was $11 million in 2024.
52 people are employed at Crystax Pharmaceuticals / Oryzon Genomics.
Crystax Pharmaceuticals / Oryzon Genomics is based in Cornella de Llobregat, Catalonia.
The NAICS codes for Crystax Pharmaceuticals / Oryzon Genomics are [54, 5416, 54171, 541711, 541, 54161, 5417, 541612].
The SIC codes for Crystax Pharmaceuticals / Oryzon Genomics are [283, 28].